|
 |
|
| |
|
Newsletter Sponsor
|
|
Whitepaper: Advancing API Development
As drug products become more sophisticated, so does the process of active pharmaceutical ingredient (API) sterilization. The sources of contamination are multiple – all posing the risk of microbial and particle intrusion, which can have negative consequences for the health of both patients and your business.
Success relies on industry-leading expertise, careful planning, flawless processes and state-of-the-art equipment and facilities. Access our free white paper to learn more!
 |
|
|
|
|
|
|
|
|
|
|
|
 |
Featured Partners |
 |
|
| |
|
|
|
The CDMO Market: A Strategic View
In this article, Frédéric Gaussens, Vice President Business Development & Strategy, Eurofins CDMO Europe (Amatsigroup SAS), details why CDMOs are a good investment value. The aim of this article is to help clients and investors to better understand what makes a difference so as to better filter their future partner selection. read more » |
|
|
|
|
|
|
|
|
|
Events
|
|
|
|
| |
|
|
|
DCAT Week ‘20
New York City, NY – 03/23/2020
DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It ...
event details » |
 |
|
|
|
|
|
INTERPHEX 2020
New York, NY – 07/15/2020
For 41 years, INTERPHEX has proven to be the place to find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture ...
event details » |
|
|
|
 |
|
|
